/
you're reading...

Systematic review does not support use of angiotensin-converting enzyme inhibitors in dogs with preclinical myxomatous mitral disease and cardiomegaly

The first comprehensive systematic review and meta-analysis on the efficacy and adverse events of the use of angiotensin-converting enzyme inhibitors (ACEIs) for the management of preclinical myxomato...

Read full story

Archives